Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
134,949,944
-
Share change
-
-6,126,852
-
Total reported value
-
$396,719,811
-
Put/Call ratio
-
166%
-
Price per share
-
$2.94
-
Number of holders
-
167
-
Value change
-
-$17,260,696
-
Number of buys
-
59
-
Number of sells
-
87
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q1 2018
As of 31 Mar 2018,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
167 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
134,949,944 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, NORTHERN TRUST CORP, MACKENZIE FINANCIAL CORP, AQR CAPITAL MANAGEMENT LLC, Connor, Clark & Lunn Investment Management Ltd., and ACADIAN ASSET MANAGEMENT LLC.
This page lists
167
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.